HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?

Abstract
The importance of arsenic trioxide (As2O3) has been underscored over the last decade due to its efficacy against acute promyelocytic leukemia (APL), a disease in which this agent has been associated with complete hematologic and molecular remission rates of 87% and 83%, respectively. The different molecular mechanisms of action of As2O3 suggest its applicability in hematologic malignancies other than APL. However, responses obtained thus far have consisted of improvements in signs and symptoms without the elimination of a given disease. Toxicities derived from As2O3 are significant but manageable and reversible. However, the risk/benefit ratio of As2O3 in hematologic malignancies other than APL is still unclear. The development of new generations of orally bioavailable inorganic, as well as new organic, arsenic compounds with improved toxicity profiles may bolster the therapeutic application of arsenic derivatives in hematologic malignancies such as leukemia, multiple myeloma and myelodysplastic syndromes.
AuthorsSrdan Verstovsek, Francis Giles, Alfonso Quintás-Cardama, Nichole Perez, Farhad Ravandi-Kashani, Miloslav Beran, Emil Freireich, Hagop Kantarjian
JournalHematological oncology (Hematol Oncol) Vol. 24 Issue 4 Pg. 181-8 (Dec 2006) ISSN: 0278-0232 [Print] England
PMID16783836 (Publication Type: Journal Article, Review)
Chemical References
  • Antineoplastic Agents
  • Arsenicals
  • Oxides
  • Arsenic Trioxide
Topics
  • Administration, Oral
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Arsenic Trioxide
  • Arsenicals (adverse effects, therapeutic use)
  • Disease-Free Survival
  • Hematologic Neoplasms (drug therapy, mortality)
  • Humans
  • Leukemia, Promyelocytic, Acute (drug therapy, mortality)
  • Oxides (adverse effects, therapeutic use)
  • Remission Induction
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: